Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,861,946 | 2,412,864 | 2,218,135 | 1,355,802 | 1,443,385 |
| Marketable Securities | 710,000 | 580,000 | 400,000 | 625,000 | 375,000 |
| Receivables | 652,992 | 716,765 | 723,639 | 698,037 | 707,095 |
| Inventories | 492,776 | 480,445 | 539,302 | 542,555 | 577,321 |
| Other current assets | 259,823 | 261,543 | 354,215 | 325,851 | 314,535 |
| TOTAL | $4,127,817 | $4,629,028 | $4,390,423 | $3,681,666 | $3,539,898 |
| Non-Current Assets | |||||
| PPE Net | 178,869 | 173,413 | 176,422 | 169,281 | 166,236 |
| Intangibles | 6,478,203 | 6,472,018 | 6,948,863 | 6,815,393 | 6,974,991 |
| Other Non-Current Assets | 749,794 | 737,798 | 740,007 | 695,528 | 645,950 |
| TOTAL | $7,406,866 | $7,383,229 | $7,865,292 | $7,680,202 | $7,787,177 |
| Total Assets | $11,534,680 | $12,012,260 | $12,255,720 | $11,361,870 | $11,327,080 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 31,000 | 31,000 | 31,000 | 605,798 | 605,375 |
| Accounts payable and accrued liabilities | 95,930 | 77,869 | 85,425 | 97,096 | 80,976 |
| Accrued Expenses | 1,063,918 | 910,947 | 858,578 | 800,993 | 826,530 |
| TOTAL | $1,222,610 | $1,038,573 | $1,029,977 | $1,556,025 | $1,562,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,336,481 | 6,077,640 | 6,080,802 | 5,100,983 | 5,105,111 |
| Other Non-Current Liabilities | 129,899 | 125,552 | 182,086 | 167,033 | 153,583 |
| TOTAL | $6,137,181 | $6,879,928 | $7,054,672 | $6,043,244 | $6,068,408 |
| Total Liabilities | $7,359,789 | $7,918,504 | $8,084,649 | $7,599,269 | $7,630,614 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,633 | 60,732 | 60,455 | 61,754 | 63,040 |
| Common Shares | 61 | 61 | 61 | 61 | 61 |
| Retained earnings | 1,035,279 | 1,127,820 | 936,705 | 871,651 | 864,511 |
| Other shareholders' equity | -785,610 | -947,667 | -603,397 | -888,227 | -882,394 |
| TOTAL | $4,174,891 | $4,093,756 | $4,171,067 | $3,762,599 | $3,696,461 |
| Total Liabilities And Equity | $11,534,680 | $12,012,260 | $12,255,716 | $11,361,868 | $11,327,075 |